Connor Clark & Lunn Investment Management Ltd. Purchases New Stake in Danaher Corporation $DHR

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 114,010 shares of the conglomerate's stock, valued at approximately $21,717,000.

Several other institutional investors have also recently bought and sold shares of DHR. High Note Wealth LLC grew its holdings in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate's stock valued at $67,000 after buying an additional 47 shares during the last quarter. First Command Advisory Services Inc. raised its holdings in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate's stock worth $253,000 after acquiring an additional 47 shares during the last quarter. GW&K Investment Management LLC lifted its position in Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate's stock valued at $138,000 after acquiring an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC boosted its stake in Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate's stock valued at $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, SOL Capital Management CO increased its holdings in Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate's stock worth $430,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

Several analysts have recently commented on the company. Guggenheim lowered their price objective on Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Stifel Nicolaus cut their target price on Danaher from $260.00 to $220.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. Royal Bank Of Canada increased their price target on Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. Wells Fargo & Company cut their price objective on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. Finally, TD Cowen reduced their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Danaher currently has an average rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Price Performance

Shares of NYSE DHR opened at $215.78 on Wednesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock's 50 day moving average price is $197.17 and its 200-day moving average price is $192.36. The company has a market capitalization of $151.69 billion, a PE ratio of 38.33, a PEG ratio of 2.68 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher's quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.77 earnings per share. On average, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source